Pharmaceutical Technology

MAY 19, 2023

DMTs for MS have a high price tag, particularly in the US. A similar trend of price increases was also seen for MS generics and biosimilars. However, they cannot provide a cure and have a very limited impact on halting disease progression.

Marketing 246

Marketing Development Drugs 246

pharmaphorum

NOVEMBER 19, 2020

Novartis/Genentech’s eye drug Lucentis could be the next big blockbuster to face competition from cheaper biosimilars after its US patent expired this year – and Samsung Bioepis and Biogen are closing in after the FDA accepted a filing for their cut-price rival.

FDA Approval 63

FDA Approval Marketing Drugs Clinical Development 63

Drug Discovery World

OCTOBER 3, 2022

She also works on her own research following her PhD in the digitisation of scientific research, smart labs and the lab of the future, and semantic tagging of scientific data, which she has continued as part of the Physical Sciences Data Infrastructure (PSDI) Project.

Drugs 52

Drugs Scientist Bioinformatics Medicine 52

pharmaphorum

DECEMBER 2, 2020

In 2015 the company also paid $17 billion to acquire Hospira , a firm specialising in injectable drugs and biosimilars, at a time when copycat biologics were starting to make real waves in the market. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. The post A history of Pfizer appeared first on.

Sales 128

Sales Production Drugs Marketing 128

Intouch Solutions

JULY 27, 2021

This new tactic illustrates the lengths to which payers are going to increase the use of biosimilars, and it previews what we can expect when Humira faces biosimilar competition in 2023. The fourth recent event was an Executive Order signed earlier this month by President Biden on “ Promoting Competition in the American Economy.”

Drugs 52

Drugs Marketing Vaccination Vaccine 52

pharmaphorum

FEBRUARY 26, 2021

But like many of its big pharma peers, it faces increased pressure on some of its biggest brands, as expiring patents pave the way for generic competition while biosimilars undercut sales of biologics. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags.

Sales 126

Sales Production Pharma Companies Marketing 126

XTalks

MARCH 22, 2023

In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more. Increased competition from generics and biosimilars has also prompted widespread change within the industry.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97